UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example AdministrableProductDefinition: TPTDteva-2080-Solution-SE-IS-APD

Generated Narrative: AdministrableProductDefinition TPTDteva-2080-Solution-SE-IS-APD

status: Active

formOf: MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001594-00053004,http://ema.europa.eu/fhir/eurdId#2903; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Solution for injection in pre-filled pen; indication = Teriparatide Teva är avsett för vuxna. Behandling av osteoporos hos postmenopausala kvinnor och hos män med ökad risk för frakturer (se avsnitt 5.1). Incidensen vertebrala och icke-vertebrala frakturer reduceras signifikant hos postmenopausala kvinnor men detta har ej visats för höftfrakturer. Behandling av osteoporos i samband med kronisk systemisk glukokortikoidbehandling hos kvinnor och män med ökad risk för frakturer (se avsnitt 5.1).; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = H05AA02

administrableDoseForm: Solution for injection

producedFrom: ManufacturedItemDefinition: status = active; manufacturedDoseForm = Solution for injection in pre-filled pen; unitOfPresentation = Pen

RouteOfAdministrations

-Code
*Subcutaneous use